tyrosine and fluvoxamine

tyrosine has been researched along with fluvoxamine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azorin, JM; Bovier, P; Jeanningros, R; Tissot, R; Widmer, J1
Bovier, P; Gaillard, JM; Tissot, R; Widmer, J1
Arcangeli, A; Crociani, O; Hancox, JC; Milnes, JT; Witchel, HJ1
Sawamura, K; Someya, T; Suzuki, Y1
Nakamura, J; Shinkai, K; Toyohira, Y; Tsutsui, M; Ueno, S; Yanagihara, N; Yoshimura, R1

Other Studies

5 other study(ies) available for tyrosine and fluvoxamine

ArticleYear
L-tyrosine and L-tryptophan membrane transport in erythrocytes and antidepressant drug choice.
    Biological psychiatry, 1990, Apr-01, Volume: 27, Issue:7

    Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder; Erythrocyte Membrane; Female; Fluvoxamine; Humans; Imipramine; Male; Mianserin; Middle Aged; Monoamine Oxidase Inhibitors; Oximes; Piperidines; Receptors, Adrenergic; Receptors, Serotonin; Tryptophan; Tyrosine

1990
Evolution of red blood cell membrane transport and plasma level of L-tyrosine and L-tryptophan in depressed treated patients according to clinical improvement.
    Neuropsychobiology, 1988, Volume: 19, Issue:3

    Topics: Adult; Aged; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Desipramine; Erythrocyte Membrane; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Oximes; Psychological Tests; Tryptophan; Tyrosine

1988
Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.
    British journal of pharmacology, 2003, Volume: 139, Issue:5

    Topics: Amino Acid Substitution; Cation Transport Proteins; Cell Line; DNA-Binding Proteins; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluvoxamine; Humans; Membrane Potentials; Mutation; Phenylalanine; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Trans-Activators; Transcriptional Regulator ERG; Tyrosine

2003
Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:4

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Chi-Square Distribution; Cytochrome P-450 CYP2D6; Depression; Female; Fluvoxamine; Humans; Japan; Male; Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Proline; Receptor, Serotonin, 5-HT2A; Serine; Tyrosine

2006
Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran.
    Naunyn-Schmiedeberg's archives of pharmacology, 2007, Volume: 375, Issue:1

    Topics: Adrenal Medulla; Animals; Antidepressive Agents; Butadienes; Catecholamines; Cattle; Cells, Cultured; Cyclopropanes; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Enzyme Activation; Fluvoxamine; Milnacipran; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; Paroxetine; Phosphorylation; Protein Kinase Inhibitors; Selective Serotonin Reuptake Inhibitors; Time Factors; Tyrosine; Tyrosine 3-Monooxygenase

2007